Ivax/Serono Oral MS Therapy Mylinax Efficacy Trials Planned For 2004
Executive Summary
Ivax and Serono hope to launch pivotal trials for their oral multiple sclerosis therapy Mylinax (cladribine) in late 2004
You may also be interested in...
Elan Meltdown May End R&D Joint Ventures As Funding Vehicle For Biotech
The Elan market meltdown is likely to shut off the joint venture route as one avenue for struggling biotech companies to obtain capital
Teva Oral Copaxone Could Be Studied At Higher Dose After Interim Analysis
Teva is considering conducting a Phase III trial evaluating a higher dose of oral Copaxone (glatiramer acetate) after an interim analysis of Teva's Phase III study of the oral formulation suggested that the trial will not meet its endpoints.
R.W. Johnson Mylinax
FDA cancels Jan. 29 meeting of the Peripheral & Central Nervous System Drugs Advisory Committee. The committee was scheduled to review Mylinax (cladribine) for treatment of multiple sclerosis